Fitusiran — catalyst calendar

2 verified catalyst event(s) referencing Fitusiran, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-15
in 2mo
ESTIMATED
READOUT
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years Wi
Phase 2/3 · Hemophilia
Genzyme, a Sanofi Company Fitusiran ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11-05
in 5mo
ESTIMATED
READOUT
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A o
Phase 3 · Hemophilia
Genzyme, a Sanofi Company Fitusiran ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.